GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test

Pharmacology Biochemistry and Behavior

Volumn 53, Issue 3, 1996, Pages 535-539

  O'Neill, Michael F ^a,b   Fernández, Andrés G ^a   Palacios, José M ^a  

^a Laboratorios Almirall ^*  (Spain)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

5 HT(1B D); Depression; GR 127935; Locomotor activity; RU 24969

Indexed keywords

4 (4 METHYL 1 PIPERAZINYL) 7 TRIFLUOROMETHYLPYRROLO[1,2 A]QUINOXALINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; ANTIDEPRESSANT AGENT; IMIPRAMINE; N TERT BUTYL 3 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL] 2 PHENYLPROPIONAMIDE; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; PAROXETINE; SEROTONIN 1A ANTAGONIST; SEROTONIN 1B AGONIST; SEROTONIN 1B ANTAGONIST; SEROTONIN 1D ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG ANTAGONISM; DRUG POTENTIATION; EXPERIMENTAL TEST; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL;

ANIMALIA; RODENTIA;

EID: 0343703434     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02047-0     Document Type: Article

References (30)

1. Artigas, F. 5-HT and antidepressants: New views from microdialysis studies. TiPs 14:262; 1993.
2. Blier, P.; De Montigny, C.; Chaput, Y. Modifications of the serotonergic system by antidepressant treatments: Implications for the therapeutic response in major depression. J. Clin. Psychopharmacol. 7:24S; 1987.
3. Boschert, U. D.; Amara, A.; Segu, L.; Hen, R. The mouse 5-hydroxytryptamine1B receptor is localized predominantly on axon terminals. Neuroscience 58:167-182; 1994.
4. Briley, M.; Moret, C. Microdialysis studies with 5-HT reuptake inhibitors. TiPs 14:396-397; 1993.
5. Carli M.; Invernizzi, R.; Cervo, L.; Samanin, R. Neurochemical and behavioural studies with RU-24969 in the rat. Psychopharmacology 94:359-364; 1988.
6. 1B receptor. Br. J. Pharmacol. 110:1621-1629; 1993.
7. 1B binding sites. Naunyn Schmiedebergs Arch. Pharmacol. 332:1-7; 1986.
8. 1A receptors. Eur. J. Pharmacol. 237:283-291; 1993.
9. Francès, H. New animal model of social behavioural deficit: Reversal by drugs. Pharmacol. Biochem. Behav. 29:467-470; 1988.
10. 1B agonist CP-93,129 facilitates striatal dopamine release in vivo. Synapse 15:90-92; 1993.
11. 2 receptors. Br. J. Pharmacol. 84:743-753; 1985.
12. 1 receptor agonist in rodents and the effect on the behaviour with treatment with antidepressants. Neuropharmacology 23:655-661; 1984.
13. Hen, R. Of mice and flies: Commonalities among 5-HT receptors. TiPS 13:160-165; 1992.
14. Hoyer, D. 5-Hydroxytryptamine receptors and effector coupling mechanisms in peripheral tissues. In: Fozard, J., ed. The peripheral actions of 5-hydroxytryptamine. Oxford: Oxford University Press; 1991:72-99.
15. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. A. International Union of Pharmacology classification of receptors for 5-Hydoroxytryptamine (serotonin). Pharmacol. Rev. 46:157-203; 1994.
16. Lucki, I.; Singh, A.; Kreiss, D. S. Antidepressant-like behavioural effects of serotonin receptor agonists. Neurosci Biobehav. Rev. 18:85-95; 1994.
17. 1B serotonin receptor: Cloning, functional expression, and localization in motor control centers. Proc. Natl. Acad. Sci. 89:3020-3024; 1992.
18. 1B receptors and the mechanisms of action of antidepressant drugs in the learned helplessness paradigm in rats? Eur. J. Pharmacol. 192:193-196; 1991.
19. 1 receptor. Naunyn Schiedebergs Arch. Pharmacol. 334:323-326; 1986.
20. 1 receptor agonist, RU 24969, inhibits the efflux of 5-hydroxytryptamine from rat frontal cortex slices by stimulation of the 5-HT autoreceptor. J. Pharm. Pharmacol. 37:434-437; 1985.
21. Neale, R. F.; Fallon, S. L.; Boyar, W. C.; Wasley, J. W. F.; Martin, L. L.; Stone, G. A.; Glaeser, B. S.; Sinton, C. M.; Williams, M. Biochemical and pharmacological characterization of CGS 12066B, a selective serotonin-IB agonist. Eur. J. Pharmacol. 136:1-9; 1987.
22. Porsolt, R. D.; McArthur, R. A.; Lenègre, A. Psychotropic screening procedures. In: van Haaren, F., ed. Methods in behavioural pharmacology. Amsterdam: Elsevier; 1993:23-51.
23. 1B receptor activation mimics behavioural effects of presynaptic serotonin release. Neuropsychopharmacology 8:201-211; 1993.
24. 1B receptor agonist with antinociceptive/antidepressive-like action in rodents. Br. J. Pharmacol. 105:732-738; 1992.
25. 1D receptor antagonist. Br. J. Pharmacol. 110: 9P; 1993.
26. 1A autoreceptors modulate 5-HT release in the guinea-pig dorsal raphé nucleus. Neuropharmacology 33:393-402; 1994.
27. 1 receptor agonist, RU 24969, in the rat. Neuropharmacology 25:877-886; 1986.
28. 1A sub-type. Eur. J. Pharmacol. 113:463-464; 1985.
29. 1D receptor: A progress review. Neurochem. Res. 13: 567-582; 1990.
30. Willner, P. Animal models as simulations of depression. TiPs 12: 131-136; 1991.